Literature DB >> 28859850

IL-4/5 signalling plays an important role during Litomosoides sigmodontis infection, influencing both immune system regulation and tissue pathology in the thoracic cavity.

Manuel Ritter1, Ruth S Tamadaho1, Judith Feid2, Wenzel Vogel3, Katharina Wiszniewsky1, Sven Perner3, Achim Hoerauf2, Laura E Layland4.   

Abstract

Approximately 100 million people suffer from filarial diseases including lymphatic filariasis (elephantiasis), onchocerciasis (river blindness) and loiasis. These diseases are amongst the most devastating of the neglected tropical diseases in terms of social and economic impact. Moreover, many infection-induced immune mechanisms in the host, their relationship to disease-related symptoms and the development of pathology within the site of infection remain unclear. To improve on current drug therapies or vaccines, further studies are necessary to decipher the mechanisms behind filaria-driven immune responses and pathology development, and thus the rodent model of Litomosoides sigmodontis can be used to unravel host-filaria interactions. Interestingly, BALB/c mice develop a patent state (release of microfilariae, the transmission life-stage, into the periphery) when exposed to L. sigmodontis. Thus, using this model, we determined levels of host inflammation and pathology development during a L. sigmodontis infection in vivo for the first known time. Our study reveals that after 30days p.i., inflammation and pathology began to develop in infected wild type BALB/c mice between the lung and diaphragm, close to the site of infection - the thoracic cavity. Interestingly, infected IL-4Rα/IL-5-/- BALB/c mice had accentuated inflammation of the pleural lung and pleural diaphragm, and higher parasite burdens. Corresponding to the pleural inflammation, levels of IP-10, MIP-1α, MIP-1β, MIP-2 and RANTES were significantly elevated in the thoracic cavity fluid of infected IL-4Rα/IL-5-/- mice compared with wild type controls. Moreover, upon L. sigmodontis antigen stimulation, IFN-γ and IL-17A secretions by cells isolated from draining lymph nodes of IL-4Rα/IL-5-/- mice were significantly elevated, whereas secretion of IL-5, IL-13 and IL-10 was reduced. Elevated filaria-specific IFN-γ secretion was also observed in spleen-derived CD4+ T cell co-cultures from IL-4Rα/IL-5-/- mice. In summary, this study unravels the essential role of IL-4/IL-5 signalling in controlling immunity against filarial infections and demonstrates the requirement of this pathway for the host to control ensuing pathology and inflammation.
Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diaphragm; IL-4Rα/IL-5(−/−); Immune regulation; Litomosoides sigmodontis; Lung; Pathology; Thoracic cavity

Mesh:

Substances:

Year:  2017        PMID: 28859850     DOI: 10.1016/j.ijpara.2017.06.009

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  11 in total

1.  The central adaptor molecule TRIF influences L. sigmodontis worm development.

Authors:  Anna Wiszniewsky; Manuel Ritter; Vanessa Krupp; Sandy Schulz; Kathrin Arndts; Heike Weighardt; Samuel Wanji; Achim Hoerauf; Laura E Layland
Journal:  Parasitol Res       Date:  2019-01-15       Impact factor: 2.289

2.  Effect of Brugia pahangi co-infection with Plasmodium berghei ANKA in gerbils (Meriones unguiculatus).

Authors:  Olawale Quazim Junaid; Indra Vythilingam; Loke Tim Khaw; Sinnadurai Sivanandam; Rohela Mahmud
Journal:  Parasitol Res       Date:  2020-03-16       Impact factor: 2.289

Review 3.  Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity.

Authors:  De'Broski R Herbert; Bonnie Douglas; Kelly Zullo
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

4.  IL-4 receptor dependent expansion of lung CD169+ macrophages in microfilaria-driven inflammation.

Authors:  Frédéric Fercoq; Estelle Remion; Stefan J Frohberger; Nathaly Vallarino-Lhermitte; Achim Hoerauf; John Le Quesne; Frédéric Landmann; Marc P Hübner; Leo M Carlin; Coralie Martin
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30

5.  Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils.

Authors:  Stefan J Frohberger; Jesuthas Ajendra; Jayagopi Surendar; Wiebke Stamminger; Alexandra Ehrens; Benedikt C Buerfent; Katrin Gentil; Achim Hoerauf; Marc P Hübner
Journal:  Parasit Vectors       Date:  2019-05-20       Impact factor: 4.047

6.  Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection.

Authors:  Valerine C Chunda; Manuel Ritter; Ayukenchengamba Bate; Narcisse V T Gandjui; Mathias E Esum; Fanny F Fombad; Abdel J Njouendou; Patrick W C Ndongmo; Mark J Taylor; Achim Hoerauf; Laura E Layland; Joseph D Turner; Samuel Wanji
Journal:  Parasit Vectors       Date:  2020-02-07       Impact factor: 3.876

7.  Microfilaria-dependent thoracic pathology associated with eosinophilic and fibrotic polyps in filaria-infected rodents.

Authors:  Frédéric Fercoq; Estelle Remion; Nathaly Vallarino-Lhermitte; Joy Alonso; Lisy Raveendran; Colin Nixon; John Le Quesne; Leo M Carlin; Coralie Martin
Journal:  Parasit Vectors       Date:  2020-11-07       Impact factor: 3.876

8.  Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia.

Authors:  Yang Peng; Xiaofang Wang; Hong Wang; Wenchun Xu; Kaifeng Wu; Xuemei Go; Yibing Yin; Xuemei Zhang
Journal:  Clin Exp Immunol       Date:  2021-07-07       Impact factor: 5.732

Review 9.  The immune response of inbred laboratory mice to Litomosoides sigmodontis: A route to discovery in myeloid cell biology.

Authors:  Conor M Finlay; Judith E Allen
Journal:  Parasite Immunol       Date:  2020-03-21       Impact factor: 2.280

Review 10.  Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model.

Authors:  Frederic Risch; Manuel Ritter; Achim Hoerauf; Marc P Hübner
Journal:  Parasitol Res       Date:  2021-02-06       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.